$1.44 Billion is the total value of Vivo Capital, LLC's 48 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 8.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SVA | Sinovac Biotech Ltd. | $615,369,410 | +1611954.1% | 5,900,000 | 0.0% | 42.70% | +871.6% | |
GTH | Genetron Holdings Ltdads | $104,570,306 | +1149150.5% | 8,124,174 | 0.0% | 7.26% | +592.4% | |
VRNA | Verona Pharma PLCads | $85,338,353 | +2346294.1% | 4,249,918 | 0.0% | 5.92% | +1313.4% | |
HRMY | Harmony Biosciences Holdings Inc | $85,093,965 | +59156.0% | 2,606,247 | 0.0% | 5.90% | -64.3% | |
TERN | Terns Pharmaceuticals Inc | $78,830,625 | +116207.1% | 6,657,992 | 0.0% | 5.47% | -29.9% | |
VRDN | Viridian Therapeutics Inc | $42,693,586 | +86994.2% | 1,678,207 | 0.0% | 2.96% | -47.5% | |
GERN | Geron Corp | $41,843,750 | +89570.3% | 19,282,834 | 0.0% | 2.90% | -46.0% | |
AVDL | Buy | Avadel Pharmaceuticals PLCadr | $34,454,772 | +174628.8% | 3,761,438 | +36.6% | 2.39% | +5.3% |
TARS | Tarsus Pharmaceuticals Inc | $28,435,854 | +85643.1% | 2,262,200 | 0.0% | 1.97% | -48.3% | |
Astria Therapeutics Inc | $22,359,947 | +89221.9% | 1,681,199 | 0.0% | 1.55% | -46.1% | ||
PCVX | Vaxcyte Inc | $21,719,960 | +78065.9% | 579,508 | 0.0% | 1.51% | -52.9% | |
COGT | Cogent Biosciences Inc | $21,525,413 | +93237.1% | 1,994,941 | 0.0% | 1.49% | -43.7% | |
KDNY | Chinook Therapeutics Inc | $20,190,296 | +88260.2% | 872,151 | 0.0% | 1.40% | -46.8% | |
Sell | Ventyx Biosciences Inc | $20,169,513 | +47096.7% | 602,075 | -53.8% | 1.40% | -71.5% | |
VECT | VectivBio Holding AG | $19,856,383 | +98111.4% | 2,333,300 | 0.0% | 1.38% | -40.8% | |
ALXO | ALX Oncology Holdings Inc | $19,074,617 | +40006.4% | 4,220,048 | 0.0% | 1.32% | -75.8% | |
ALLK | Allakos Inc | $18,334,596 | +52749.6% | 4,120,134 | 0.0% | 1.27% | -68.2% | |
ZLAB | Buy | Zai Lab Ltd ADRadr | $13,857,446 | +133157.5% | 416,640 | +23.0% | 0.96% | -19.6% |
LEGN | Legend Biotech Corp Sponsoredsponsored ads | $11,783,763 | +96496.1% | 244,375 | 0.0% | 0.82% | -41.8% | |
CMPX | Sell | Compass Therapeutics Inc | $11,628,195 | +64880.1% | 3,556,023 | -0.0% | 0.81% | -60.8% |
AMRS | Amyris, Inc | $10,541,126 | +88787.1% | 7,750,828 | 0.0% | 0.73% | -46.4% | |
New | Arcellx Inc. | $8,956,868 | – | 290,713 | +100.0% | 0.62% | – | |
TIL | Instil Bio Inc | $8,251,269 | +104784.6% | 12,486,787 | 0.0% | 0.57% | -36.8% | |
BLU | Bellus Health Inc | $7,323,494 | +87491.1% | 1,017,152 | 0.0% | 0.51% | -47.2% | |
ACRS | Aclaris Therapeutics, Inc. | $7,269,925 | +51266.7% | 898,631 | 0.0% | 0.50% | -69.1% | |
Sera Prognostics Inc | $7,108,522 | +303812.9% | 1,856,011 | 0.0% | 0.49% | +83.3% | ||
KALV | KalVista Pharmaceuticals Inc. | $6,728,223 | +116164.4% | 856,008 | 0.0% | 0.47% | -29.9% | |
DYN | Dyne Therapeutics Inc | $6,654,436 | +99294.1% | 577,642 | 0.0% | 0.46% | -40.1% | |
MRUS | Sell | Merus NV | $6,506,240 | +95791.5% | 353,600 | -19.4% | 0.45% | -42.3% |
Aadi Bioscience Inc | $6,456,277 | +98650.0% | 509,572 | 0.0% | 0.45% | -40.5% | ||
OLMA | Olema Pharmaceuticals Inc | $5,862,617 | +141543.3% | 1,689,515 | 0.0% | 0.41% | -14.7% | |
IO Biotech Inc | $5,654,147 | +81418.8% | 3,015,545 | 0.0% | 0.39% | -50.9% | ||
BOLT | Bolt Therapeutics Inc | $5,381,094 | +106816.2% | 3,871,291 | 0.0% | 0.37% | -35.6% | |
DBVT | DBV Technologies SAsponsored adr | $4,577,999 | +110346.3% | 2,708,875 | 0.0% | 0.32% | -33.3% | |
IMPL | Impel NeuroPharma Inc | $4,038,705 | +9233.3% | 2,884,789 | 0.0% | 0.28% | -94.4% | |
IOVA | Iovance Biotherapeutics Inc | $4,002,398 | +95513.9% | 655,057 | 0.0% | 0.28% | -42.3% | |
ARWR | Arrowhead Pharmaceuticals Inc | $3,490,239 | +62527.7% | 137,411 | 0.0% | 0.24% | -62.3% | |
ALGS | Aligos Therapeutics Inc | $3,100,104 | +91619.1% | 3,547,030 | 0.0% | 0.22% | -44.7% | |
GRCL | Buy | Gracell Biotechnologies Incsponsored ads | $2,723,008 | +123057.3% | 1,463,983 | +52.3% | 0.19% | -25.9% |
BCAB | BioAtla Inc | $1,707,645 | +32383.3% | 637,181 | 0.0% | 0.12% | -80.5% | |
ASLN | Aslan Pharmaceuticals Ltdads | $1,636,364 | +159857.4% | 2,840,909 | 0.0% | 0.11% | -3.4% | |
CDXS | Codexis, Inc | $1,606,916 | +88729.0% | 388,144 | 0.0% | 0.11% | -46.2% | |
FULC | New | Fulcrum Therapeutics Inc | $1,567,500 | – | 550,000 | +100.0% | 0.11% | – |
IMUX | Immunic Inc | $941,954 | +112979.7% | 632,184 | 0.0% | 0.06% | -32.3% | |
RZLT | Rezolute Inc | $939,788 | +92672.8% | 489,473 | 0.0% | 0.06% | -44.4% | |
Minerva Surgical Inc | $486,339 | +98150.3% | 2,215,667 | 0.0% | 0.03% | -40.4% | ||
FIXX | Homology Medicines, Inc. | $381,170 | +81696.1% | 370,068 | 0.0% | 0.03% | -51.9% | |
DTIL | Precision Biosciences Inc | $105,696 | +63191.0% | 140,255 | 0.0% | 0.01% | -63.2% | |
Exit | Cincor Pharma Inc | $0 | – | -421,635 | -100.0% | -0.60% | – | |
VERA | Exit | Vera Therapeutics Inc | $0 | – | -400,666 | -100.0% | -0.89% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ACLARIS THERAPEUTICS INC | 29 | Q3 2023 | 33.5% |
CODEXIS INC | 29 | Q3 2023 | 8.0% |
ASCENDIS PHARMA A/S | 25 | Q3 2022 | 24.0% |
KALVISTA PHARMACEUTICALS INC | 25 | Q3 2023 | 3.9% |
Verona Pharma PLC ADR | 24 | Q3 2023 | 7.6% |
AMYRIS INC | 23 | Q3 2023 | 8.8% |
EIGER BIOPHARMACEUTICALS INC | 23 | Q1 2022 | 8.7% |
Zai Lab Ltd ADR | 22 | Q3 2023 | 1.8% |
Arrowhead Pharmaceuticals Inc | 21 | Q3 2023 | 6.9% |
HOMOLOGY MEDICINES INC | 21 | Q3 2023 | 3.7% |
View Vivo Capital, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
SINOVAC BIOTECH LTDSold out | August 27, 2018 | 0 | 0.0% |
View Vivo Capital, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-07 |
13F-HR | 2023-11-08 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
13F-HR | 2021-11-15 |
View Vivo Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.